 Aldeyra Therapeutics, Inc. Nasdaq: ALDX Aldeyra today announced that Todd C. Brady, M.D., Ph.D., President and Chief Executive Officer, will discuss the companys clinical programs in anterior and posterior ocular disease as part of the Ophthalmology Innovation Summits Virtual Public Company Showcase on Thursday, July 16, 2020. Dr. Bradys presentation is scheduled for 1:40 to 1:50 p.m. ET. 